Vaidya Sane Ayurved Laboratories Limited MADHAVBAUGshare price and chart
Vaidya Sane Ayurved Laboratories closed at ₹154.50 on 19 November 2026, down 4.51% on the day. The 52-week range is ₹130.05 to ₹335.00.
Daily candlesEach candle is one trading day. The chart opens on the last year; drag back past the start or open full screen and the rest loads, back to listing (or the first day in our data). The body runs from the open to the close, the thin lines to the high and low. Green closed up, red closed down.
Loading prices…
Split and bonus adjusted daily candles. Drag back past the start, or open full screen, and its whole history loads. Scroll or pinch to zoom; full screen adds indicators, drawing and measuring.Test a strategy on MADHAVBAUG
Real prices, every charge counted. Pick one or write your own.Technical snapshotHow the share has been behaving: its momentum, its trend, how much of the trading was real buying to keep, and its returns.
EOD 19 NovThe share of traded quantity that was actually delivered (not squared off intraday) - high delivery vs its 20-session average suggests real buying or holding, not just churn.
Returns and valuationWhat the market pays for this company and how well the business uses its money.
Books to 30 Sept 2026Against its sectorWhere this company ranks among similar companies on each measure.
Medical Equipment & Supplies · 16 peers · mediansDividend historyCash the company has paid per share, year by year.
2023 paid ₹0.25 per share, about ₹162 on ₹1 lakh at today's price. Dividends are at the company's discretion and can be cut or skipped.
What it has returnedThe yearly growth rate in the share price over each period, as if it had grown smoothly.
Price only, before dividendsHeld for 3 years this compounded at -16.6% a year. The last twelve months were down -44.2%. Price only, before dividends.
Shareholding patternThe share of the company held by its promoters, by foreign and domestic institutions, and by the public, quarter by quarter.
Who owns itThe promoter/promoter-group stake as a percentage of total shares, each quarter since listing. A rising line means promoters are adding to their stake; a falling one often means dilution, pledge-driven sales, or stake sales to new investors.
Recent announcementsThe company's own filings to the exchange in the last six months: results, board meetings, investor calls and more, each with its source document.
Last 6 monthsKey ratios at a glanceThe eight figures most people check first, each placed against companies in the same industry.
Against its sectorPeers are the listed companies in the exchange's own industry group: Medical Equipment & Supplies. Balance-sheet figures are from the latest filed balance sheet; trends show each financial year we hold.
Cash flowProfit is an accounting figure. Cash flow shows the money that really moved: in from the business, out on investments, and to or from lenders and shareholders.
Where the cash wentIn FY26 cash fell by ₹2 Cr, after ₹8 Cr spent on plant and equipment.
Health check, year by yearMargins, returns and debt for each financial year, so you can see the direction.
| Measure | FY25 | FY26 |
|---|---|---|
| ROCEHow much operating profit the company made on all the money in the business, whether it came from owners or lenders. | 15.6% | 16.9% |
| Debt to equityBorrowings compared with the shareholders' money. 1 means the company owes as much as its owners have put in; 0 means no borrowings. | 0.02x | 0.04x |
Each row against this company's own usual level: green better, red worse, grey close to it.
Peers side by sideCompanies in the same exchange-defined industry group, largest first. Tap a heading to sort.
Medical Equipment & Supplies| Company | What the whole company is worth on the stock market: share price times the number of shares. It measures size, not quality. | How many rupees investors pay today for one rupee of the company's yearly profit. A P/E of 20 means paying ₹20 for ₹1 of annual profit. | The share price against the shareholders' money per share on the balance sheet. It asks what you pay for each rupee the owners have in the business. | How much profit the company made on the shareholders' money in the business. 15% means ₹15 of profit a year on every ₹100 of owners' money. | How much operating profit the company made on all the money in the business, whether it came from owners or lenders. | Borrowings compared with the shareholders' money. 1 means the company owes as much as its owners have put in; 0 means no borrowings. | Of every ₹100 of sales, how much is left as profit after all costs, interest and tax. | How much sales grew in the latest quarter against the same quarter a year earlier. | The cash paid out in a year as a percentage of today's share price. A 2% yield means ₹2 a year on a ₹100 share. |
|---|---|---|---|---|---|---|---|---|---|
| MOLBIO Molbio Diagnostics Limited | 17,590 cr | - | 12.2x | - | - | 0.22 | - | - | 0.00% |
| POLYMED Poly Medicure Limited | 16,933 cr | 53.2x | 5.2x | 10.8% | 13.7% | 0.12 | 14.8% | +30.8% | 0.21% |
| TARSONS Tarsons Products Limited | 1,616 cr | 215.4x | 2.5x | 2.3% | 4.5% | 0.61 | 1.6% | +20.8% | 0.00% |
| FISCHER Fischer Medical Ventures Limited | 1,496 cr | 87.9x | 3.2x | 8.1% | 11.5% | 0.11 | 4.3% | +24.5% | 0.22% |
| LAXMIDENTL Laxmi Dental Limited | 1,060 cr | 32.7x | 4.0x | 12.8% | 13.1% | 0.00 | 11.0% | +10.0% | 0.00% |
| QLINE Q-Line Biotech Limited | 952 cr | 12.8x | 2.0x | - | 19.5% | 0.27 | 15.4% | - | 0.00% |
| DENTALKART Vasa Denticity Limited | 840 cr | 69.7x | 4.4x | - | 9.1% | 0.00 | 3.8% | - | 0.00% |
| FABTECH Fabtech Technologies Limited | 593 cr | 15.7x | 1.4x | 9.1% | 11.3% | 0.07 | 9.2% | -24.2% | 0.45% |
| OSELDEVICE Osel Devices Limited | 527 cr | 23.8x | 2.3x | - | 23.9% | 0.64 | 9.5% | - | 0.34% |
| QMSMEDI QMS Medical Allied Services Limited | 331 cr | - | 3.6x | - | - | 0.86 | - | - | 0.29% |
| NURECA Nureca Limited | 285 cr | 60.7x | 1.5x | 1.1% | 3.3% | 0.01 | 2.7% | +55.1% | 0.00% |
| APRAMEYA Aprameya Engineering Limited | 238 cr | - | - | - | - | - | - | - | 0.00% |
| MADHAVBAUG Vaidya Sane Ayurved Laboratories Limited | 162 cr | 41.3x | 2.3x | - | 16.9% | 0.18 | 3.4% | +17.5% | 0.00% |
| AVIENCE Avience Biomedicals Limited | 138 cr | 12.2x | 2.2x | - | 23.2% | 0.44 | 17.2% | - | 0.00% |
| MHHL Mohini Health & Hygiene Limited | 49 cr | - | 0.5x | - | -9.9% | 1.62 | -4.1% | +50.2% | 0.00% |
| GKB GKB Ophthalmics Limited | 30 cr | 6.0x | - | - | - | - | 3.2% | +8.5% | 0.00% |
| GML Galaxy Medicare Limited | 26 cr | 8.7x | 0.6x | - | 11.2% | 0.10 | 7.1% | +7.8% | 4.15% |
Swipe the table sideways for more columns. Tap a heading to sort. A dash means the figure is not filed or cannot be worked out for that company. A bigger cohort is cut to its 40 largest companies.
Monthly price changeThe share's price change in every calendar month, one row per year, so you can check for yourself whether a month has a pattern.
Month by month| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Year |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | -20.4 | -4.5 | -22.9 | +47.7 | -25.7 | -1.1 | +7.1 | -12.7 | +2.1 | -21.2 | +13.6 | · | -45.7% 11m |
| 2025 | -10.1 | -22.0 | -3.5 | +33.4 | +20.6 | +5.4 | +46.7 | +21.3 | +2.5 | -6.7 | +1.0 | +4.2 | +105.4% |
| 2024 | +2.5 | -1.5 | -18.5 | +13.7 | -19.6 | +5.7 | -18.1 | +9.1 | -4.9 | -4.7 | +7.4 | -5.1 | -34.5% |
| 2023 | +15.6 | -2.4 | +15.7 | -2.9 | +10.4 | -2.1 | +27.7 | +10.2 | -10.7 | -5.2 | -22.0 | -7.7 | +17.6% |
| 2022 | · | · | +63.1 | -2.6 | -5.2 | -14.0 | -7.4 | -2.4 | -1.4 | -4.1 | +4.9 | +29.7 | +50.6% 10m |
Month-on-month change in closing price, adjusted for splits and bonuses but not for dividends, so a large dividend shows up here as a fall. Starts from 1995, when the exchange began trading equities, or from the stock's listing if later. This is a record of what happened, not a forecast.
Deals and filingsLarge trades reported to the exchange, plus the company's documents sorted by type.
| Date | Party | Side | Quantity | Price | Value |
|---|---|---|---|---|---|
| 2022-02-24 | DHYANAM CAPITAL · bulk | BUY | 1,52,000 | ₹101.90 | ₹1.55 Cr |
| 2022-02-23 | DHYANAM CAPITAL · bulk | BUY | 2,64,000 | ₹101.77 | ₹2.69 Cr |
| 2022-02-23 | SHARAD HARLALKA · bulk | BUY | 64,000 | ₹106.94 | ₹0.68 Cr |
- Board outcomeOutcome of Board Meeting18 Nov 2026
Vaidya Sane Ayurved Laboratories Limited has submitted to the Exchange, the financial results for the period ended September 30, 2026.
- Board outcomeOutcome of Board Meeting5 Nov 2026
Vaidya Sane Ayurved Laboratories Limited has submitted to the Exchange, the financial results for the period ended September 30, 2026.
- Board outcomeOutcome of Board Meeting15 May 2026
Vaidya Sane Ayurved Laboratories Limited has submitted to the Exchange, the financial results for the period ended March 31, 2026.
- Board outcomeOutcome of Board Meeting5 Nov 2025
Vaidya Sane Ayurved Laboratories Limited has submitted to the Exchange, the financial results for the period ended September 30, 2025.
- Board outcomeOutcome of Board Meeting22 May 2025
Vaidya Sane Ayurved Laboratories Limited has submitted to the Exchange, the financial results for the period ended March 31, 2025.
The last two years of the company's filings to the exchange, grouped by the exchange's own categories. Each opens the original document.
Read enough? Test MADHAVBAUG. “Buy MADHAVBAUG when RSI(14) drops below 30, sell at 10% profit or after 20 days.” Real prices, every charge counted.
Run it free